Rectifying Errors and an Apology for a Study of Possible Differential Effects of an Intervention Among Black and White Patients
- PMID: 37171823
- DOI: 10.1001/jamanetworkopen.2023.19588
Rectifying Errors and an Apology for a Study of Possible Differential Effects of an Intervention Among Black and White Patients
Comment on
-
Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2023 Apr 3;6(4):e2310877. doi: 10.1001/jamanetworkopen.2023.10877. JAMA Netw Open. 2023. PMID: 37103935 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical